USFDA grants Sun Pharma subsidiary approval for generic Strattera capsules ANDA
September 2nd, 2010
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Strattera ®, atomoxetine hydrochloride capsules.
Original post by macular degeneration – Google News
(click on the author/publication link above to see full post)